Skip to content
Search
Topic · standing beatupdated Sun, 1 Nov, 04:30

FDA

1 story · 1 outlet · last 7 days

Stories

1

+1vs prior 7d (0)

Read: Coverage rose against the previous seven days.

n=1 · last 7 days · stream A · coverage · floor 5

Measured claims

0

0 corroborated · 0 contested

Read: Claims another outlet's reporting corroborated, and claims another outlet's reporting contradicted. Neither is a verdict on whether the claim is true.

n=0 · last 7 days · stream A · coverage · floor 5

Most-flagged phrase

Not enough coverage (n=0, need 5)

Read: The phrase this beat's stories most often flagged as loaded, and how many used it at all. We do not suggest what a newsroom should have written instead.

n=0 · last 7 days · stream A · coverage · floor 5

This week’s lead · most outlets

Health · 31 Oct

GLP-1 Medicine | మార్కెట్లో కుప్పలు కుప్ప‌లుగా క‌ల్తీ జీఎల్‌పీ-1 మందులు.. అమెరికా ఎఫ్‌డీఏ హెచ్చ‌రిక‌లు..

AI summaryThe US FDA issued import alerts against two Chinese pharmaceutical manufacturers, Chengdu ShengNuo Bio-Pharm and Nanjing ChengAng Pharmaceutical, for sanitary deficiencies and quality control negligence during inspections. The alert, listed under 66-40, prevents these companies' products from entering the US market. The article notes that while these conditions were found, it does not confirm that the products have actually caused harm to patients.

1 outlet

Everything on this beat

ranked by relevance, not counted in the figures above

20 stories loaded